fig1
![Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies](https://image.oaes.cc/f8842838-ac00-4722-bd2a-6c96768a2e5d/3204.fig.1.jpg)
Figure 1. Plausible mechanisms of cancer drug resistance. The mechanisms can generally be classified as pharmacological and cellular physiological mechanisms, which either feed into or feed out of the well-known and characterised hallmarks of cancer[12]